Shopping Cart
- Remove All
- Your shopping cart is currently empty
LH1753 is an orally active inhibitor of L-cystine crystallization, with an EC50 of 29.5 nM. It is applicable in research related to Cystinuria.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | LH1753 is an orally active inhibitor of L-cystine crystallization, with an EC50 of 29.5 nM. It is applicable in research related to Cystinuria. |
In vivo | LH1753 (150 μmol/kg, administered orally, once daily for eight weeks) inhibits the formation of L-cystine stones but does not affect the growth of the cystinuria mouse model with Slc3a1 gene knockout [1]. |
Molecular Weight | 630.57 |
Formula | C22H44Cl4N6O2S2 |
Cas No. | 2650492-10-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.